Here's Why Bliss GVS Pharma (NSE:BLISSGVS) Has Caught The Eye Of Investors - simplywall.st
2024-10-26 • Google News
Bliss GVS Pharma Limited (BLISSGVS)
NSEINR 118.776.2%
Price Chart
Key Statistics
Market Cap
INR 12.54B
P/E Ratio
21.10
Revenue (TTM)
INR 8.1B
Volume
302.29K
52W High
INR 185.50
52W Low
INR 91.74
Dividend Yield
0.43%
Beta
0.93
Technicals
50-Day MA
120.9162
200-Day MA
134.3667
52 Week High
185.5
52 Week Low
91.736
About BLISSGVS
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India and internationally. The company offers pharma products, including capsules, creams/gels/ointments, dr.
Employees
831
Headquarters
Mumbai, India
CEO
Mr. Gagan Harsh Sharma
Latest News
Bliss GVS Pharma Faces Market Sentiment Shift Amid Declining Financial Performance - MarketsMojo
2025-04-09 • Google News
Bliss GVS Pharma gains 5% on bagging EU GMP certification for two units - Business Standard
2024-11-25 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg